The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus

Diabetic Medicine

Volumn 15, Issue 3, 1998, Pages 194-198

  Gudat, U ^a   Bungert, S ^a   Kemmer, F ^a   Heinemann, L ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Dept of Metab Dis and Nutrition ^*  (Germany)

Author keywords

Blood glucose; Exercise; Glibenclamide; Type 2 diabetes mellitus

Indexed keywords

GLIBENCLAMIDE; INSULIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; ENDURANCE; EXERCISE; HEMOGLOBIN DETERMINATION; HUMAN; HYPOGLYCEMIA; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; EXERCISE; GLUCAGON; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LACTIC ACID; MIDDLE AGED;

EID: 0031881658     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199803)15:3<194::AID-DIA546>3.0.CO;2-2     Document Type: Article

References (8)

1. Mitchell TH, Cosio MG, Magder SA, Marliss EB. Metabolic responses during and after incremental exercise in normal subjects. Diab Nutr Metab 1989; 2: 199-207.
2. Kemmer FW, Tacken M, Berger M. Mechanism of exercise-induced hypoglycaemia during sulfonylurea treatment. Diabetes 1987; 36: 1178-1182.
3. Gudat L, Heinemann L. Influence of physical exercise on glycaemia in healthy subjects following administration of the sulfonylurea glimepiride. Arzneimittelforschung/Drug Research 1996; 46: 606-609.
4. Minuk HL, Vranic M, Marliss EB, Hanna AK, Albisser AM, Zinman B. The glucoregulatory response to exercise in obese non-insulin dependent diabetes. Am J Physiol 1981; 240: E458-E464.
5. Coppack SW, Lanf AF, McIntosh CS, Rodgers AV. Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin dependent diabetes mellitus. Br J Clin Pharmac 1990; 29: 673-684.
6. Arnqvist HJ, Karlberg BE, Melander A. Pharmacokinetics and effects of glibenclamide in two formulations, HB 419 and HB 240, in type 2 diabetes. Ann Clin Res 1983; 15 (suppl 37): 21-25.
7. Groop L, Barzilai N, Ratheiser K, Luzi L, Wåhlin-Boll E, Melander A, DeFronzo RA. Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans. Diabetes Care 1991; 14: 724-727.
8. Massi-Benedetti M, Herz M, Pfeiffer C. The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide. Horm Metab Res 1996; 28: 451-455.